ENPP2 and melanoma: To further investigate the effects of thio-ccPA 18:1 on melanoma cells and determine whether targeting the LPA3 receptor has a complementary role to ATX inhibition, we examined LPA receptor-mediated cell viability using A375 melanoma cells.